ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

eGenesis Appoints Jodie Morrison as Chief Executive Officer and President – Business Wire (press release)

eGenesis Appoints Jodie Morrison as Chief Executive Officer and PresidentBusiness Wire (press release)CRISPR refers to Clustered Regularly Interspaced Short Palindromic Repeats occurring in the genome of certain bacteria. CRISPR technology uses a prote… Continue reading

2017-09-26 Michael Zand NEWS

Upchuck factor: Alcoholism targeted with novel gene therapy – Genetic Literacy Project

Genetic Literacy ProjectUpchuck factor: Alcoholism targeted with novel gene therapyGenetic Literacy ProjectThe intense nausea that follows drinking alcohol for people with a certain gene variant may become the basis for a gene therapy to prevent alcoho… Continue reading

2017-09-26 Michael Zand NEWS

British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies – Labiotech.eu (blog)

Continue reading

2017-09-26 Michael Zand NEWS

British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies – Labiotech.eu (blog)

British Biotech Pockets Massive Series C for its CAR–T Cancer Therapies
Labiotech.eu (blog)
Autolus, based in London, has raised €68M in Series C to continue developing its T cell immunotherapies for cancer treatment. Autolus focuses on developing engineered T cell immunotherapies to beat cancer. Its pipeline includes therapies targeted at …

Continue reading

2017-09-26 Michael Zand NEWS

Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal … – GlobeNewswire (press release)

Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal …GlobeNewswire (press release)CAMBRIDGE, Mass., Sept. 26, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome… Continue reading

2017-09-26 Michael Zand NEWS

Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal … – GlobeNewswire (press release)

Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal …GlobeNewswire (press release)CAMBRIDGE, Mass., Sept. 26, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome… Continue reading

2017-09-26 Michael Zand NEWS

Syncona leads $80 mln round for gene therapy firm Autolus – Reuters

Syncona leads $80 mln round for gene therapy firm AutolusReutersLONDON, Sept 26 (Reuters) – Syncona has led a $80 million investment in Autolus, a company developing gene therapies to treat cancer, the healthcare investment group said on Tuesday. Gene-… Continue reading

2017-09-26 Michael Zand NEWS

A ‘social control’ system guarantees embryonic stem cell purity – Phys.Org

British Biotech Pockets Massive Series C for its CAR–T Cancer Therapies
Labiotech.eu (blog)
Autolus, based in London, has raised €68M in Series C to continue developing its T cell immunotherapies for cancer treatment. Autolus focuses on developing engineered T cell immunotherapies to beat cancer. Its pipeline includes therapies targeted at …

Continue reading

2017-09-26 Michael Zand NEWS
  • 1
  • …
  • 1,145
  • 1,146
  • 1,147
  • 1,148
  • 1,149
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Phys.Org

A ‘social control’ system guarantees embryonic stem cell purity
Phys.Org
A sophisticated system of “social control” operating between neighboring cells allows embryos to protect the purity of their pluripotent cell population, which is able to generate all body tissues. This system works through the elimination of cells …